RELAY THERAPEUTICS INC (RLAY)
US75943R1023 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -345.20M | -341.97M | -290.51M | -363.87M | -52.41M | |||
| Depreciation Amortization | 5.51M | 5.27M | 4.13M | 3.93M | 3.55M | |||
| Change In Working Capital | -7.43M | -32.46M | 11.25M | 97.34M | -85.17M | |||
| Other non cash items | 66.69M | 68.85M | 45.64M | 188.20M | 31.54M | |||
| OPERATING CASH FLOW | -280.43M | -300.32M | -229.49M | -74.41M | -102.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.13M | -4.13M | -9.06M | -3.47M | -1.93M | |||
| Other Investing Activity | -8.26M | 261.76M | -179.68M | -476.04M | 83.60M | |||
| INVESTING CASH FLOW | -10.41M | 257.63M | -188.75M | -479.51M | 81.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 291.27M | 34.75M | 289.91M | 388.09M | 429.02M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -2.51M | |||
| FINANCING CASH FLOW | 291.27M | 34.75M | 289.91M | 388.09M | 426.51M | |||
| CHANGE IN CASH | 434.00K | -7.93M | -128.33M | -165.83M | 405.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -280.43M | -300.32M | -229.49M | -74.41M | -102.49M | |||
| Capital Expenditure | -2.13M | -4.13M | -9.06M | -3.47M | -1.93M | |||
| FREE CASH FLOW | -282.56M | -304.44M | -238.55M | -77.88M | -104.42M | |||
All data in USD